查看購物車
  • Simplified Chinese
  • English
  • Japanese
普拉睪酮 (CAS 53-43-0) 全球市場 2025
市場調查報告書
商品編碼
1673098

普拉睪酮 (CAS 53-43-0) 全球市場 2025

Global Prasterone (CAS 53-43-0) Market Research Report 2025
出版日期: | 出版商: QYResearch | 英文 122 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計 2024 年全球 Prasterone（CAS 53-43-0）市場規模為 4,928 萬美元。

預計預測期內（2025-2031 年），市場複合年成長率為 7.17%，到 2031 年將達到 7,592 萬美元。

北美 Prasterone（CAS 53-43-0）市場規模預計在 2024 年達到 1,452 萬美元。預計預測期內（2025-2031 年），市場複合年成長率為 7.18%，到 2031 年將達到 2,318 萬美元。

預計 2024 年亞太地區普拉斯特酮 (CAS 53-43-0) 市場規模將達到 2,762 萬美元。預計預測期內（2025-2031 年），市場複合年成長率為 7.55%，到 2031 年將達到 4,247 萬美元。

全球主要的普拉睪酮 (CAS 53-43-0) 生產廠商包括宜城五藤藥業、君野藥業、湖北丹奧藥業、湖北竹溪人福藥業、山東齊藤生物科技等。 2024年，全球前五大供應商將佔據73.42%的營收。

本報告研究了全球 Prasterone（CAS 53-43-0）市場，並提供了市場概述以及按類型、應用和地區分類的趨勢，以及參與市場的公司概況。

目錄

第 1 章 普拉睪酮 (CAS 53-43-0) 市場概覽

  • 產品定義
  • 普拉睪酮（CAS 53-43-0），依類型
  • 普拉睪酮（CAS 53-43-0），依用途
  • 全球市場成長前景
  • 假設和限制

第2章 廠商市場競爭格局

3. 普拉睪酮（CAS 53-43-0）產量（依地區）

  • 2020 年、2024 年和 2031 年全球普拉斯特酮 (CAS 53-43-0) 產量預測（按地區分類）
  • 2020 年至 2031 年全球普拉睪酮 (CAS 53-43-0) 產量（按地區）
  • 全球普拉斯特酮 (CAS 53-43-0) 產量預測：2020 年 vs. 2024 年 vs. 2031 年，按地區分類
  • 2020 年至 2031 年全球普拉睪酮 (CAS 53-43-0) 產量（按地區）
  • 2020 年至 2025 年全球普拉斯特酮 (CAS 53-43-0) 市場價格分析（按地區）
  • 全球普拉睪酮 (CAS 53-43-0) 產量和產值、與前一年同期比較成長率

4. 普拉睪酮（CAS 53-43-0）的各地區消費量

  • 全球普拉斯特酮 (CAS 53-43-0)消費量預測：2020 年 vs. 2024 年 vs. 2031 年，按地區分類
  • 2020 年至 2031 年全球普拉睪酮 (CAS 53-43-0)消費量（按地區）
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲

第5章 按類型分類

  • 全球普拉斯特酮 (CAS 53-43-0) 產量（按類型）（2020 年至 2031 年）
  • 全球普拉斯特酮 (CAS 53-43-0) 產值（按類型）（2020-2031 年）
  • 全球普拉斯特酮 (CAS 53-43-0) 價格，按類型分類（2020-2031 年）

第6章 按應用程式分類

  • 全球普拉睪酮 (CAS 53-43-0) 產量，依應用分類（2020 年至 2031 年）
  • 全球普拉斯特酮 (CAS 53-43-0) 產值依應用分類（2020-2031 年）
  • 全球普拉斯特酮 (CAS 53-43-0) 價格按應用分類（2020-2031 年）

第7章主要企業簡介

  • Yicheng Goto Pharmaceuticals Co.,Ltd.
  • Junye Pharmaceutical Co., Ltd.
  • Hubei Dan'ao Pharmaceutical Co., Ltd.
  • Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd
  • Shandong Saito Biotechnology Co., Ltd
  • Jiangsu Jiaerke Pharmaceuticals Group
  • Zhejiang Shenzhou Pharmaceutical Co., Ltd
  • HuBei WuDang AnTai Pharmaceutical Co
  • Symbiotec Pharma Lab Pvt. Ltd.
  • NutriScience Innovations, LLC

第8章產業鍊及銷售管道分析

  • 普拉睪酮（CAS 53-43-0）產業鏈分析
  • 普拉睪酮 (CAS 53-43-0) 原料供應分析
  • 普拉睪酮（CAS 53-43-0）製造模式及製程分析
  • Prasterone (CAS 53-43-0) 客戶分析

第 9 章普拉睪酮 (CAS 53-43-0) 市場動態

第 10 章調查結果與結論

第 11 章調查方法與資料來源

The global Prasterone (CAS 53-43-0) market was valued at US$ 49.28 million in 2024 and is anticipated to reach US$ 75.92 million by 2031, witnessing a CAGR of 7.17% during the forecast period 2025-2031.

North American market for Prasterone (CAS 53-43-0) is estimated to increase from $ 14.52 million in 2024 to reach $ 23.18 million by 2031, at a CAGR of 7.18% during the forecast period of 2025 through 2031.

Asia-Pacific market for Prasterone (CAS 53-43-0) is estimated to increase from $ 27.62 million in 2024 to reach $ 42.47 million by 2031, at a CAGR of 7.55% during the forecast period of 2025 through 2031.

The major global manufacturers of Prasterone (CAS 53-43-0) include Yicheng Goto Pharmaceutical, Junye Pharmaceutical, Hubei Dan'ao Pharmaceutical, Hubei Zhuxi Humanwell Pharmaceutical and Shandong Saito Biotechnology, and etc. In 2024, the world's top five vendors accounted for 73.42% of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Prasterone (CAS 53-43-0), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prasterone (CAS 53-43-0).

The Prasterone (CAS 53-43-0) market size, estimations, and forecasts are provided in terms of output/shipments (kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Prasterone (CAS 53-43-0) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Prasterone (CAS 53-43-0) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Yicheng Goto Pharmaceutical
  • Junye Pharmaceutical
  • Hubei Dan'ao Pharmaceutical
  • Hubei Zhuxi Humanwell Pharmaceutical
  • Shandong Saito Biotechnology
  • Jiangsu Jiaerke Pharmaceutical
  • Zhejiang Shenzhou Pharmaceutical
  • Wudang Antai Pharmaceutical
  • Symbiotec
  • NutriScience Innovations

Segment by Type

  • >=99%
  • Others

Segment by Application

  • Medicine
  • Dietary Supplements
  • Skin Care Products
  • Reagents
  • Others

Production by Region

  • North America
  • Europe
  • China

Consumption by Region

  • North America
  • U.S.
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Rest of Europe
  • Latin America, Middle East & Africa

Chapter Outline:

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Prasterone (CAS 53-43-0) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Production/output, value of Prasterone (CAS 53-43-0) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 4: Consumption of Prasterone (CAS 53-43-0) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 10: The main points and conclusions of the report.

Table of Contents

1 Prasterone (CAS 53-43-0) Market Overview

  • 1.1 Product Definition
  • 1.2 Prasterone (CAS 53-43-0) by Type
    • 1.2.1 Global Prasterone (CAS 53-43-0) Market Value Growth Rate Analysis by Type: 2024 VS 2031
    • 1.2.2 >= 99)
    • 1.2.3 Others
  • 1.3 Prasterone (CAS 53-43-0) by Application
    • 1.3.1 Global Prasterone (CAS 53-43-0) Market Value Growth Rate Analysis by Application: 2024 VS 2031
    • 1.3.2 Medicine
    • 1.3.3 Dietary Supplements
    • 1.3.4 Skin Care Products
    • 1.3.5 Reagents
    • 1.3.6 Others
  • 1.4 Global Market Growth Prospects
    • 1.4.1 Global Prasterone (CAS 53-43-0) Production Value Estimates and Forecasts (2020-2031)
    • 1.4.2 Global Prasterone (CAS 53-43-0) Production Capacity Estimates and Forecasts (2020-2031)
    • 1.4.3 Global Prasterone (CAS 53-43-0) Production Estimates and Forecasts (2020-2031)
    • 1.4.4 Global Prasterone (CAS 53-43-0) Market Average Price Estimates and Forecasts (2020-2031)
  • 1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

  • 2.1 Global Prasterone (CAS 53-43-0) Production Market Share by Manufacturers (2020-2025)
  • 2.2 Global Prasterone (CAS 53-43-0) Production Value Market Share by Manufacturers (2020-2025)
  • 2.3 Global Key Players of Prasterone (CAS 53-43-0), Industry Ranking, 2024 VS 2025
  • 2.4 Global Prasterone (CAS 53-43-0) Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 2.5 Global Prasterone (CAS 53-43-0) Average Price by Manufacturers (2020-2025)
  • 2.6 Global Key Manufacturers of Prasterone (CAS 53-43-0), Manufacturing Sites & Headquarters
  • 2.7 Global Key Manufacturers of Prasterone (CAS 53-43-0), Product Type & Application
  • 2.8 Global Prasterone (CAS 53-43-0) Market Competitive Situation and Trends
    • 2.8.1 Global Prasterone (CAS 53-43-0) Market Concentration Rate
    • 2.8.2 Global 5 and 10 Largest Prasterone (CAS 53-43-0) Players Market Share by Revenue

3 Prasterone (CAS 53-43-0) Production by Region

  • 3.1 Global Prasterone (CAS 53-43-0) Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
  • 3.2 Global Prasterone (CAS 53-43-0) Production Value by Region (2020-2031)
    • 3.2.1 Global Prasterone (CAS 53-43-0) Production Value Market Share by Region (2020-2025)
    • 3.2.2 Global Forecasted Production Value of Prasterone (CAS 53-43-0) by Region (2026-2031)
  • 3.3 Global Prasterone (CAS 53-43-0) Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
  • 3.4 Global Prasterone (CAS 53-43-0) Production by Region (2020-2031)
    • 3.4.1 Global Prasterone (CAS 53-43-0) Production Market Share by Region (2020-2025)
    • 3.4.2 Global Forecasted Production of Prasterone (CAS 53-43-0) by Region (2026-2031)
  • 3.5 Global Prasterone (CAS 53-43-0) Market Price Analysis by Region (2020-2025)
  • 3.6 Global Prasterone (CAS 53-43-0) Production and Value, Year-over-Year Growth
    • 3.6.1 North America Prasterone (CAS 53-43-0) Production Value Estimates and Forecasts (2020-2031)
    • 3.6.2 Europe Prasterone (CAS 53-43-0) Production Value Estimates and Forecasts (2020-2031)
    • 3.6.3 China Prasterone (CAS 53-43-0) Production Value Estimates and Forecasts (2020-2031)

4 Prasterone (CAS 53-43-0) Consumption by Region

  • 4.1 Global Prasterone (CAS 53-43-0) Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
  • 4.2 Global Prasterone (CAS 53-43-0) Consumption by Region (2020-2031)
    • 4.2.1 Global Prasterone (CAS 53-43-0) Consumption by Region (2020-2031)
    • 4.2.2 Global Prasterone (CAS 53-43-0) Forecasted Consumption by Region (2026-2031)
  • 4.3 North America
    • 4.3.1 North America Prasterone (CAS 53-43-0) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
    • 4.3.2 North America Prasterone (CAS 53-43-0) Consumption by Country (2020-2031)
    • 4.3.3 U.S.
    • 4.3.4 Canada
  • 4.4 Europe
    • 4.4.1 Europe Prasterone (CAS 53-43-0) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
    • 4.4.2 Europe Prasterone (CAS 53-43-0) Consumption by Country (2020-2031)
    • 4.4.3 Germany
    • 4.4.4 France
    • 4.4.5 U.K.
    • 4.4.6 Italy
  • 4.5 Asia Pacific
    • 4.5.1 Asia Pacific Prasterone (CAS 53-43-0) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
    • 4.5.2 Asia Pacific Prasterone (CAS 53-43-0) Consumption by Region (2020-2031)
    • 4.5.3 China
    • 4.5.4 Japan
    • 4.5.5 India
  • 4.6 Latin America
  • 4.7 Middle East and Africa

5 Segment by Type

  • 5.1 Global Prasterone (CAS 53-43-0) Production by Type (2020-2031)
    • 5.1.1 Global Prasterone (CAS 53-43-0) Production by Type (2020-2025)
    • 5.1.2 Global Prasterone (CAS 53-43-0) Production by Type (2026-2031)
    • 5.1.3 Global Prasterone (CAS 53-43-0) Production Market Share by Type (2020-2031)
  • 5.2 Global Prasterone (CAS 53-43-0) Production Value by Type (2020-2031)
    • 5.2.1 Global Prasterone (CAS 53-43-0) Production Value by Type (2020-2025)
    • 5.2.2 Global Prasterone (CAS 53-43-0) Production Value by Type (2026-2031)
    • 5.2.3 Global Prasterone (CAS 53-43-0) Production Value Market Share by Type (2020-2031)
  • 5.3 Global Prasterone (CAS 53-43-0) Price by Type (2020-2031)

6 Segment by Application

  • 6.1 Global Prasterone (CAS 53-43-0) Production by Application (2020-2031)
    • 6.1.1 Global Prasterone (CAS 53-43-0) Production by Application (2020-2025)
    • 6.1.2 Global Prasterone (CAS 53-43-0) Production by Application (2026-2031)
    • 6.1.3 Global Prasterone (CAS 53-43-0) Production Market Share by Application (2020-2031)
  • 6.2 Global Prasterone (CAS 53-43-0) Production Value by Application (2020-2031)
    • 6.2.1 Global Prasterone (CAS 53-43-0) Production Value by Application (2020-2025)
    • 6.2.2 Global Prasterone (CAS 53-43-0) Production Value by Application (2026-2031)
    • 6.2.3 Global Prasterone (CAS 53-43-0) Production Value Market Share by Application (2020-2031)
  • 6.3 Global Prasterone (CAS 53-43-0) Price by Application (2020-2031)

7 Key Companies Profiled

  • 7.1 Yicheng Goto Pharmaceuticals Co.,Ltd.
    • 7.1.1 Yicheng Goto Pharmaceuticals Co.,Ltd. Prasterone (CAS 53-43-0) Company Information
    • 7.1.2 Yicheng Goto Pharmaceuticals Co.,Ltd. Prasterone (CAS 53-43-0) Product Portfolio
    • 7.1.3 Yicheng Goto Pharmaceuticals Co.,Ltd. Prasterone (CAS 53-43-0) Production, Value, Price and Gross Margin (2020-2025)
    • 7.1.4 Yicheng Goto Pharmaceuticals Co.,Ltd. Main Business and Markets Served
  • 7.2 Junye Pharmaceutical Co., Ltd.
    • 7.2.1 Junye Pharmaceutical Co., Ltd. Prasterone (CAS 53-43-0) Company Information
    • 7.2.2 Junye Pharmaceutical Co., Ltd. Prasterone (CAS 53-43-0) Product Portfolio
    • 7.2.3 Junye Pharmaceutical Co., Ltd. Prasterone (CAS 53-43-0) Production, Value, Price and Gross Margin (2020-2025)
    • 7.2.4 Junye Pharmaceutical Co., Ltd. Main Business and Markets Served
  • 7.3 Hubei Dan'ao Pharmaceutical Co., Ltd.
    • 7.3.1 Hubei Dan'ao Pharmaceutical Co., Ltd. Prasterone (CAS 53-43-0) Company Information
    • 7.3.2 Hubei Dan'ao Pharmaceutical Co., Ltd. Prasterone (CAS 53-43-0) Product Portfolio
    • 7.3.3 Hubei Dan'ao Pharmaceutical Co., Ltd. Prasterone (CAS 53-43-0) Production, Value, Price and Gross Margin (2020-2025)
    • 7.3.4 Hubei Dan'ao Pharmaceutical Co., Ltd. Main Business and Markets Served
  • 7.4 Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd.
    • 7.4.1 Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Prasterone (CAS 53-43-0) Company Information
    • 7.4.2 Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Prasterone (CAS 53-43-0) Product Portfolio
    • 7.4.3 Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Prasterone (CAS 53-43-0) Production, Value, Price and Gross Margin (2020-2025)
    • 7.4.4 Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Main Business and Markets Served
  • 7.5 Shandong Saito Biotechnology Co., Ltd.
    • 7.5.1 Shandong Saito Biotechnology Co., Ltd. Prasterone (CAS 53-43-0) Company Information
    • 7.5.2 Shandong Saito Biotechnology Co., Ltd. Prasterone (CAS 53-43-0) Product Portfolio
    • 7.5.3 Shandong Saito Biotechnology Co., Ltd. Prasterone (CAS 53-43-0) Production, Value, Price and Gross Margin (2020-2025)
    • 7.5.4 Shandong Saito Biotechnology Co., Ltd. Main Business and Markets Served
  • 7.6 Jiangsu Jiaerke Pharmaceuticals Group
    • 7.6.1 Jiangsu Jiaerke Pharmaceuticals Group Prasterone (CAS 53-43-0) Company Information
    • 7.6.2 Jiangsu Jiaerke Pharmaceuticals Group Prasterone (CAS 53-43-0) Product Portfolio
    • 7.6.3 Jiangsu Jiaerke Pharmaceuticals Group Prasterone (CAS 53-43-0) Production, Value, Price and Gross Margin (2020-2025)
    • 7.6.4 Jiangsu Jiaerke Pharmaceuticals Group Main Business and Markets Served
  • 7.7 Zhejiang Shenzhou Pharmaceutical Co., Ltd.
    • 7.7.1 Zhejiang Shenzhou Pharmaceutical Co., Ltd. Prasterone (CAS 53-43-0) Company Information
    • 7.7.2 Zhejiang Shenzhou Pharmaceutical Co., Ltd. Prasterone (CAS 53-43-0) Product Portfolio
    • 7.7.3 Zhejiang Shenzhou Pharmaceutical Co., Ltd. Prasterone (CAS 53-43-0) Production, Value, Price and Gross Margin (2020-2025)
    • 7.7.4 Zhejiang Shenzhou Pharmaceutical Co., Ltd. Main Business and Markets Served
  • 7.8 HuBei WuDang AnTai Pharmaceutical Co
    • 7.8.1 HuBei WuDang AnTai Pharmaceutical Co Prasterone (CAS 53-43-0) Company Information
    • 7.8.2 HuBei WuDang AnTai Pharmaceutical Co Prasterone (CAS 53-43-0) Product Portfolio
    • 7.8.3 HuBei WuDang AnTai Pharmaceutical Co Prasterone (CAS 53-43-0) Production, Value, Price and Gross Margin (2020-2025)
    • 7.8.4 HuBei WuDang AnTai Pharmaceutical Co Main Business and Markets Served
  • 7.9 Symbiotec Pharma Lab Pvt. Ltd.
    • 7.9.1 Symbiotec Pharma Lab Pvt. Ltd. Prasterone (CAS 53-43-0) Company Information
    • 7.9.2 Symbiotec Pharma Lab Pvt. Ltd. Prasterone (CAS 53-43-0) Product Portfolio
    • 7.9.3 Symbiotec Pharma Lab Pvt. Ltd. Prasterone (CAS 53-43-0) Production, Value, Price and Gross Margin (2020-2025)
    • 7.9.4 Symbiotec Pharma Lab Pvt. Ltd. Main Business and Markets Served
  • 7.10 NutriScience Innovations, LLC
    • 7.10.1 NutriScience Innovations, LLC Prasterone (CAS 53-43-0) Company Information
    • 7.10.2 NutriScience Innovations, LLC Prasterone (CAS 53-43-0) Product Portfolio
    • 7.10.3 NutriScience Innovations, LLC Prasterone (CAS 53-43-0) Production, Value, Price and Gross Margin (2020-2025)
    • 7.10.4 NutriScience Innovations, LLC Main Business and Markets Served
    • 7.10.5 NutriScience Innovations, LLC Recent Developments/Updates

8 Industry Chain and Sales Channels Analysis

  • 8.1 Prasterone (CAS 53-43-0) Industry Chain Analysis
  • 8.2 Prasterone (CAS 53-43-0) Raw Material Supply Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
  • 8.3 Prasterone (CAS 53-43-0) Production Mode & Process Analysis
  • 8.4 Prasterone (CAS 53-43-0) Customer Analysis

9 Prasterone (CAS 53-43-0) Market Dynamics

  • 9.1 Prasterone (CAS 53-43-0) Industry Trends
  • 9.2 Prasterone (CAS 53-43-0) Market Drivers
  • 9.3 Prasterone (CAS 53-43-0) Market Challenges and Restraints

10 Research Findings and Conclusion

11 Methodology and Data Source

  • 11.1 Methodology/Research Approach
    • 11.1.1 Research Programs/Design
    • 11.1.2 Market Size Estimation
    • 11.1.3 Market Breakdown and Data Triangulation
  • 11.2 Data Source
    • 11.2.1 Secondary Sources
    • 11.2.2 Primary Sources
  • 11.3 Author List
  • 11.4 Disclaimer

List of Tables

  • Table 1. Global Prasterone (CAS 53-43-0) Market Value by Type, (US$ million) & (2024 VS 2031)
  • Table 2. Global Prasterone (CAS 53-43-0) Market Value by Application, (US$ million) & (2024 VS 2031)
  • Table 3. Global Prasterone (CAS 53-43-0) Production by Manufacturers (2020-2025) & (kg)
  • Table 4. Global Prasterone (CAS 53-43-0) Production Market Share by Manufacturers (2020-2025)
  • Table 5. Global Prasterone (CAS 53-43-0) Production Value by Manufacturers (2020-2025) & (US$ million)
  • Table 6. Global Prasterone (CAS 53-43-0) Production Value Share by Manufacturers (2020-2025)
  • Table 7. Global Key Players of Prasterone (CAS 53-43-0), Industry Ranking, 2024 VS 2025
  • Table 8. Global Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Prasterone (CAS 53-43-0) as of 2024)
  • Table 9. Global Market Prasterone (CAS 53-43-0) Average Price by Manufacturers (US$/kg) & (2020-2025)
  • Table 10. Global Key Manufacturers of Prasterone (CAS 53-43-0), Manufacturing Sites & Headquarters
  • Table 11. Global Key Manufacturers of Prasterone (CAS 53-43-0), Product Type & Application
  • Table 12. Global Prasterone (CAS 53-43-0) Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 13. Global Prasterone (CAS 53-43-0) Production Value Growth Rate by Region: 2020 VS 2024 VS 2031 (US$ million)
  • Table 14. Global Prasterone (CAS 53-43-0) Production Value (US$ million) by Region (2020-2025)
  • Table 15. Global Prasterone (CAS 53-43-0) Production Value Market Share by Region (2020-2025)
  • Table 16. Global Prasterone (CAS 53-43-0) Production Value (US$ million) Forecast by Region (2026-2031)
  • Table 17. Global Prasterone (CAS 53-43-0) Production Value Market Share Forecast by Region (2026-2031)
  • Table 18. Global Prasterone (CAS 53-43-0) Production Comparison by Region: 2020 VS 2024 VS 2031 (kg)
  • Table 19. Global Prasterone (CAS 53-43-0) Production (kg) by Region (2020-2025)
  • Table 20. Global Prasterone (CAS 53-43-0) Production Market Share by Region (2020-2025)
  • Table 21. Global Prasterone (CAS 53-43-0) Production (kg) Forecast by Region (2026-2031)
  • Table 22. Global Prasterone (CAS 53-43-0) Production Market Share Forecast by Region (2026-2031)
  • Table 23. Global Prasterone (CAS 53-43-0) Market Average Price (US$/kg) by Region (2020-2025)
  • Table 24. Global Prasterone (CAS 53-43-0) Market Average Price (US$/kg) by Region (2026-2031)
  • Table 25. Global Prasterone (CAS 53-43-0) Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (kg)
  • Table 26. Global Prasterone (CAS 53-43-0) Consumption by Region (2020-2025) & (kg)
  • Table 27. Global Prasterone (CAS 53-43-0) Consumption Market Share by Region (2020-2025)
  • Table 28. Global Prasterone (CAS 53-43-0) Forecasted Consumption by Region (2026-2031) & (kg)
  • Table 29. Global Prasterone (CAS 53-43-0) Forecasted Consumption Market Share by Region (2020-2025)
  • Table 30. North America Prasterone (CAS 53-43-0) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (kg)
  • Table 31. North America Prasterone (CAS 53-43-0) Consumption by Country (2020-2025) & (kg)
  • Table 32. North America Prasterone (CAS 53-43-0) Consumption by Country (2026-2031) & (kg)
  • Table 33. Europe Prasterone (CAS 53-43-0) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (kg)
  • Table 34. Europe Prasterone (CAS 53-43-0) Consumption by Country (2020-2025) & (kg)
  • Table 35. Europe Prasterone (CAS 53-43-0) Consumption by Country (2026-2031) & (kg)
  • Table 36. Asia Pacific Prasterone (CAS 53-43-0) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (kg)
  • Table 37. Asia Pacific Prasterone (CAS 53-43-0) Consumption by Region (2020-2025) & (kg)
  • Table 38. Asia Pacific Prasterone (CAS 53-43-0) Consumption by Region (2026-2031) & (kg)
  • Table 39. Global Prasterone (CAS 53-43-0) Production (kg) by Type (2020-2025)
  • Table 40. Global Prasterone (CAS 53-43-0) Production (kg) by Type (2026-2031)
  • Table 41. Global Prasterone (CAS 53-43-0) Production Market Share by Type (2020-2025)
  • Table 42. Global Prasterone (CAS 53-43-0) Production Market Share by Type (2026-2031)
  • Table 43. Global Prasterone (CAS 53-43-0) Production Value (US$ million) by Type (2020-2025)
  • Table 44. Global Prasterone (CAS 53-43-0) Production Value (US$ million) by Type (2026-2031)
  • Table 45. Global Prasterone (CAS 53-43-0) Production Value Market Share by Type (2020-2025)
  • Table 46. Global Prasterone (CAS 53-43-0) Production Value Market Share by Type (2026-2031)
  • Table 47. Global Prasterone (CAS 53-43-0) Price (US$/kg) by Type (2020-2025)
  • Table 48. Global Prasterone (CAS 53-43-0) Price (US$/kg) by Type (2026-2031)
  • Table 49. Global Prasterone (CAS 53-43-0) Production (kg) by Application (2020-2025)
  • Table 50. Global Prasterone (CAS 53-43-0) Production (kg) by Application (2026-2031)
  • Table 51. Global Prasterone (CAS 53-43-0) Production Market Share by Application (2020-2025)
  • Table 52. Global Prasterone (CAS 53-43-0) Production Market Share by Application (2026-2031)
  • Table 53. Global Prasterone (CAS 53-43-0) Production Value (US$ million) by Application (2020-2025)
  • Table 54. Global Prasterone (CAS 53-43-0) Production Value (US$ million) by Application (2026-2031)
  • Table 55. Global Prasterone (CAS 53-43-0) Production Value Market Share by Application (2020-2025)
  • Table 56. Global Prasterone (CAS 53-43-0) Production Value Market Share by Application (2026-2031)
  • Table 57. Global Prasterone (CAS 53-43-0) Price (US$/kg) by Application (2020-2025)
  • Table 58. Global Prasterone (CAS 53-43-0) Price (US$/kg) by Application (2026-2031)
  • Table 59. Yicheng Goto Pharmaceuticals Co.,Ltd. Prasterone (CAS 53-43-0) Company Information
  • Table 60. Yicheng Goto Pharmaceuticals Co.,Ltd. Prasterone (CAS 53-43-0) Specification and Application
  • Table 61. Yicheng Goto Pharmaceuticals Co.,Ltd. Prasterone (CAS 53-43-0) Production (kg), Value (US$ million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 62. Yicheng Goto Pharmaceuticals Co.,Ltd. Main Business and Markets Served
  • Table 63. Junye Pharmaceutical Co., Ltd. Prasterone (CAS 53-43-0) Company Information
  • Table 64. Junye Pharmaceutical Co., Ltd. Prasterone (CAS 53-43-0) Specification and Application
  • Table 65. Junye Pharmaceutical Co., Ltd. Prasterone (CAS 53-43-0) Production (kg), Value (US$ million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 66. Junye Pharmaceutical Co., Ltd. Main Business and Markets Served
  • Table 67. Hubei Dan'ao Pharmaceutical Co., Ltd. Prasterone (CAS 53-43-0) Company Information
  • Table 68. Hubei Dan'ao Pharmaceutical Co., Ltd. Prasterone (CAS 53-43-0) Specification and Application
  • Table 69. Hubei Dan'ao Pharmaceutical Co., Ltd. Prasterone (CAS 53-43-0) Production (kg), Value (US$ million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 70. Hubei Dan'ao Pharmaceutical Co., Ltd. Main Business and Markets Served
  • Table 71. Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Prasterone (CAS 53-43-0) Company Information
  • Table 72. Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Prasterone (CAS 53-43-0) Specification and Application
  • Table 73. Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Prasterone (CAS 53-43-0) Production (kg), Value (US$ million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 74. Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Main Business and Markets Served
  • Table 75. Shandong Saito Biotechnology Co., Ltd. Prasterone (CAS 53-43-0) Company Information
  • Table 76. Shandong Saito Biotechnology Co., Ltd. Prasterone (CAS 53-43-0) Specification and Application
  • Table 77. Shandong Saito Biotechnology Co., Ltd. Prasterone (CAS 53-43-0) Production (kg), Value (US$ million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 78. Shandong Saito Biotechnology Co., Ltd. Main Business and Markets Served
  • Table 79. Jiangsu Jiaerke Pharmaceuticals Group Prasterone (CAS 53-43-0) Company Information
  • Table 80. Jiangsu Jiaerke Pharmaceuticals Group Prasterone (CAS 53-43-0) Specification and Application
  • Table 81. Jiangsu Jiaerke Pharmaceuticals Group Prasterone (CAS 53-43-0) Production (kg), Value (US$ million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 82. Jiangsu Jiaerke Pharmaceuticals Group Main Business and Markets Served
  • Table 83. Zhejiang Shenzhou Pharmaceutical Co., Ltd. Prasterone (CAS 53-43-0) Company Information
  • Table 84. Zhejiang Shenzhou Pharmaceutical Co., Ltd. Prasterone (CAS 53-43-0) Specification and Application
  • Table 85. Zhejiang Shenzhou Pharmaceutical Co., Ltd. Prasterone (CAS 53-43-0) Production (kg), Value (US$ million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 86. Zhejiang Shenzhou Pharmaceutical Co., Ltd. Main Business and Markets Served
  • Table 87. HuBei WuDang AnTai Pharmaceutical Co Prasterone (CAS 53-43-0) Company Information
  • Table 88. HuBei WuDang AnTai Pharmaceutical Co Prasterone (CAS 53-43-0) Specification and Application
  • Table 89. HuBei WuDang AnTai Pharmaceutical Co Prasterone (CAS 53-43-0) Production (kg), Value (US$ million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 90. HuBei WuDang AnTai Pharmaceutical Co Main Business and Markets Served
  • Table 91. Symbiotec Pharma Lab Pvt. Ltd. Prasterone (CAS 53-43-0) Company Information
  • Table 92. Symbiotec Pharma Lab Pvt. Ltd. Prasterone (CAS 53-43-0) Specification and Application
  • Table 93. Symbiotec Pharma Lab Pvt. Ltd. Prasterone (CAS 53-43-0) Production (kg), Value (US$ million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 94. Symbiotec Pharma Lab Pvt. Ltd. Main Business and Markets Served
  • Table 95. NutriScience Innovations, LLC Prasterone (CAS 53-43-0) Company Information
  • Table 96. NutriScience Innovations, LLC Prasterone (CAS 53-43-0) Specification and Application
  • Table 97. NutriScience Innovations, LLC Prasterone (CAS 53-43-0) Production (kg), Value (US$ million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 98. NutriScience Innovations, LLC Main Business and Markets Served
  • Table 99. NutriScience Innovations, LLC Recent Developments/Updates
  • Table 100. Key Raw Materials Lists
  • Table 101. Raw Materials Key Suppliers Lists
  • Table 102. Prasterone (CAS 53-43-0) Customers List
  • Table 103. Prasterone (CAS 53-43-0) Market Trends
  • Table 104. Prasterone (CAS 53-43-0) Market Drivers
  • Table 105. Prasterone (CAS 53-43-0) Market Challenges and Restraints
  • Table 106. Research Programs/Design for This Report
  • Table 107. Key Data Information from Secondary Sources
  • Table 108. Key Data Information from Primary Sources
  • Table 109. Authors List of This Report

List of Figures

  • Figure 1. Product Picture of Prasterone (CAS 53-43-0)
  • Figure 2. Global Prasterone (CAS 53-43-0) Market Value by Type, (US$ million) & (2020 VS 2024 VS 2031)
  • Figure 3. Global Prasterone (CAS 53-43-0) Market Share by Type: 2024 VS 2031
  • Figure 4. Global Prasterone (CAS 53-43-0) Market Value by Application, (US$ million) & (2024 VS 2031)
  • Figure 5. Global Prasterone (CAS 53-43-0) Market Share by Application: 2024 VS 2031
  • Figure 6. Medicine
  • Figure 7. Dietary Supplements
  • Figure 8. Skin Care Products
  • Figure 9. Reagents
  • Figure 10. Experimental Application
  • Figure 11. Global Prasterone (CAS 53-43-0) Production Value (US$ million), 2020 VS 2024 VS 2031
  • Figure 12. Global Prasterone (CAS 53-43-0) Production Value (US$ million) & (2020-2031)
  • Figure 13. Global Prasterone (CAS 53-43-0) Production Capacity (kg) & (2020-2031)
  • Figure 14. Global Prasterone (CAS 53-43-0) Production (kg) & (2020-2031)
  • Figure 15. Global Prasterone (CAS 53-43-0) Average Price (US$/kg) & (2020-2031)
  • Figure 16. Prasterone (CAS 53-43-0) Report Years Considered
  • Figure 17. Prasterone (CAS 53-43-0) Production Share by Manufacturers in 2024
  • Figure 18. Prasterone (CAS 53-43-0) Production Value Share by Manufacturers in 2024
  • Figure 19. Prasterone (CAS 53-43-0) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 20. The Global 5 and 10 Largest Players: Market Share by Prasterone (CAS 53-43-0) Revenue in 2024
  • Figure 21. Global Prasterone (CAS 53-43-0) Production Value Comparison by Region: 2020 VS 2024 VS 2031 (US$ million)
  • Figure 22. Global Prasterone (CAS 53-43-0) Production Value Market Share by Region: 2020 VS 2024 VS 2031
  • Figure 23. Global Prasterone (CAS 53-43-0) Production Comparison by Region: 2020 VS 2024 VS 2031 (kg)
  • Figure 24. Global Prasterone (CAS 53-43-0) Production Market Share by Region: 2020 VS 2024 VS 2031
  • Figure 25. North America Prasterone (CAS 53-43-0) Production Value (US$ million) Growth Rate (2020-2031)
  • Figure 26. Europe Prasterone (CAS 53-43-0) Production Value (US$ million) Growth Rate (2020-2031)
  • Figure 27. China Prasterone (CAS 53-43-0) Production Value (US$ million) Growth Rate (2020-2031)
  • Figure 28. Global Prasterone (CAS 53-43-0) Consumption by Region: 2020 VS 2024 VS 2031 (kg)
  • Figure 29. Global Prasterone (CAS 53-43-0) Consumption Market Share by Region: 2020 VS 2024 VS 2031
  • Figure 30. North America Prasterone (CAS 53-43-0) Consumption and Growth Rate (2020-2031) & (kg)
  • Figure 31. North America Prasterone (CAS 53-43-0) Consumption Market Share by Country (2020-2031)
  • Figure 32. U.S. Prasterone (CAS 53-43-0) Consumption and Growth Rate (2020-2031) & (kg)
  • Figure 33. Canada Prasterone (CAS 53-43-0) Consumption and Growth Rate (2020-2031) & (kg)
  • Figure 34. Europe Prasterone (CAS 53-43-0) Consumption and Growth Rate (2020-2031) & (kg)
  • Figure 35. Europe Prasterone (CAS 53-43-0) Consumption Market Share by Country (2020-2031)
  • Figure 36. Germany Prasterone (CAS 53-43-0) Consumption and Growth Rate (2020-2031) & (kg)
  • Figure 37. France Prasterone (CAS 53-43-0) Consumption and Growth Rate (2020-2031) & (kg)
  • Figure 38. U.K. Prasterone (CAS 53-43-0) Consumption and Growth Rate (2020-2031) & (kg)
  • Figure 39. Italy Prasterone (CAS 53-43-0) Consumption and Growth Rate (2020-2031) & (kg)
  • Figure 40. Asia Pacific Prasterone (CAS 53-43-0) Consumption and Growth Rate (2020-2031) & (kg)
  • Figure 41. Asia Pacific Prasterone (CAS 53-43-0) Consumption Market Share by Region (2026-2031)
  • Figure 42. China Prasterone (CAS 53-43-0) Consumption and Growth Rate (2020-2031) & (kg)
  • Figure 43. Japan Prasterone (CAS 53-43-0) Consumption and Growth Rate (2020-2031) & (kg)
  • Figure 44. India Prasterone (CAS 53-43-0) Consumption and Growth Rate (2020-2031) & (kg)
  • Figure 45. Latin America Prasterone (CAS 53-43-0) Consumption and Growth Rate (2020-2031) & (kg)
  • Figure 46. Middle East and Africa Prasterone (CAS 53-43-0) Consumption and Growth Rate (2020-2031) & (kg)
  • Figure 47. Global Production Market Share of Prasterone (CAS 53-43-0) by Type (2020-2031)
  • Figure 48. Global Production Value Market Share of Prasterone (CAS 53-43-0) by Type (2020-2031)
  • Figure 49. Global Prasterone (CAS 53-43-0) Price (US$/kg) by Type (2020-2031)
  • Figure 50. Global Production Market Share of Prasterone (CAS 53-43-0) by Application (2020-2031)
  • Figure 51. Global Production Value Market Share of Prasterone (CAS 53-43-0) by Application (2020-2031)
  • Figure 52. Global Prasterone (CAS 53-43-0) Price (US$/kg) by Application (2020-2031)
  • Figure 53. Prasterone (CAS 53-43-0) Value Chain
  • Figure 54. Bottom-up and Top-down Approaches for This Report
  • Figure 55. Data Triangulation